- 专利标题： GPR40 agonists for the treatment of type II diabetes
-
申请号： US15228031申请日： 2016-08-04
-
公开(公告)号： US09908873B2公开(公告)日： 2018-03-06
- 发明人: Hui Huang , Sanath Meegalla , Mark R. Player
- 申请人： Janssen Pharmaceutica NV
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica NV
- 当前专利权人： Janssen Pharmaceutica NV
- 当前专利权人地址： BE Beerse
- 主分类号： C07D413/12
- IPC分类号： C07D413/12 ; C07D333/16 ; C07D413/04 ; C07D261/12 ; C07D231/12 ; C07D333/24 ; C07D275/02 ; C07D401/12 ; C07D401/04 ; C07D409/04 ; C07D233/64 ; C07D249/06 ; C07D261/08
摘要：
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (II) as follows: wherein R1B, R2B, R4B, WB, XB, YB, and GB, are defined herein.
公开/授权文献
- US20170044147A1 GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES 公开/授权日：2017-02-16
信息查询
